Erythromycin and Sulfisoxazole

Generic name: Pronounced as (er ith roe mye' sin) (sul fi sox' a zole)
Brand names
  • Eryzole®
  • Ilosone®
  • Pediazole®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 05/15/2019

The combination of erythromycin and sulfisoxazole (a sulfa drug) is used to treat certain ear infections caused by bacteria. It usually is used in children.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Erythromycin and sulfisoxazole comes as a liquid to take by mouth. It usually is taken every 6 hours (four times a day) for 10 days. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take erythromycin and sulfisoxazole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Shake the liquid well before each use to mix the medication evenly.

Drink a full glass of water after each dose.

Continue to take erythromycin and sulfisoxazole even if you feel well. Do not stop taking erythromycin and sulfisoxazole without talking to your doctor.

Before taking erythromycin and sulfisoxazole,

  • tell your doctor and pharmacist if you are allergic to erythromycin and sulfisoxazole, azithromycin (Zithromax), clarithromycin (Biaxin), dirithromycin (Dynabac), medication for diabetes, diuretics ('water pills'), or any other drugs.

  • tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially other antibiotics, anticoagulants ('blood thinners') such as warfarin (Coumadin), astemizole (Hismanal), carbamazepine (Tegretol), clozapine (clozaril), cyclosporine (Neoral, Sandimmune), digoxin (Lanoxin), disopyramide (Norpace), ergotamine, felodipine (Plendil), lovastatin (Mevacor), oral contraceptives, phenytoin (Dilantin), terfenadine (Seldane), theophylline (Theo-Dur), triazolam (Halcion), and vitamins.

  • tell your doctor if you have or have ever had kidney or liver disease, allergies, anemia, asthma, glucose-6-phosphate dehydrogenase (G-6-PD) deficiency, yellowing of the skin or eyes, colitis, or stomach problems.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking erythromycin and sulfisoxazole, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking erythromycin and sulfisoxazole.

Do not take this medication with, or just after, fruit juices, carbonated drinks, or tea. It can be taken with or between meals.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Erythromycin and sulfisoxazole may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • upset stomach

    • diarrhea

    • vomiting

    • stomach cramps

    • mild skin rash

  • If you experience any of the following symptoms, call your doctor immediately:

    • severe skin rash

    • itching

    • hives

    • difficulty breathing or swallowing

    • wheezing

    • stomach pain

    • yellowing of the skin or eyes

    • dark urine

    • pale stools

    • unusual tiredness

    • sore throat

    • fever

    • joint pain

    • blood in urine

    • unusual bleeding or bruising

    • dark, tarry stools

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Keep it in the refrigerator, and dispose of any unused medication after 14 days. Do not freeze.

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your response to erythromycin and sulfisoxazole.

Do not let anyone else take your medication. Your prescription is probably not refillable. If you still have symptoms of infection after you finish the erythromycin and sulfisoxazole, call your doctor.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Moxifloxacin.
Repaglinide Repaglinide The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.
Delavirdine Delavirdine The metabolism of Erythromycin can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Erythromycin.
Atorvastatin Atorvastatin The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Erythromycin.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Anagrelide.
Candesartan Candesartan The excretion of Erythromycin can be decreased when combined with Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Erythromycin.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The excretion of Conjugated estrogens can be decreased when combined with Erythromycin.
Fenofibrate Fenofibrate Erythromycin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Methylergonovine Methylergonovine Erythromycin may increase the vasoconstricting activities of Methylergometrine.
Paregoric Paregoric The serum concentration of Morphine can be increased when it is combined with Erythromycin.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Acebutolol.
Prednisone Prednisone The serum concentration of Erythromycin can be increased when it is combined with Prednisone.
Reserpine Reserpine The risk or severity of liver damage can be increased when Erythromycin is combined with Reserpine.
Sumatriptan Sumatriptan The excretion of Sumatriptan can be decreased when combined with Erythromycin.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Erythromycin.
Triamcinolone Triamcinolone Triamcinolone may decrease the excretion rate of Erythromycin which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Erythromycin.
Fluconazole Injection Fluconazole Injection Fluconazole may increase the QTc-prolonging and arrhythmogenic activities of Erythromycin.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Erythromycin.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Erythromycin.
Methylprednisolone Injection Methylprednisolone Injection The serum concentration of Methylprednisolone can be increased when it is combined with Erythromycin.
Metoclopramide Injection Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Erythromycin.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Erythromycin.
Morphine Injection Morphine Injection The serum concentration of Morphine can be increased when it is combined with Erythromycin.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Erythromycin.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Erythromycin.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Erythromycin is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Granisetron.
Torsemide Torsemide The excretion of Torasemide can be decreased when combined with Erythromycin.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Erythromycin.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Erythromycin.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Erythromycin.
Oxcarbazepine Oxcarbazepine The metabolism of Erythromycin can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole The excretion of Erythromycin can be decreased when combined with Pantoprazole.
Telmisartan Telmisartan Erythromycin may decrease the excretion rate of Telmisartan which could result in a higher serum level.
Zaleplon Zaleplon The metabolism of Zaleplon can be decreased when combined with Erythromycin.
Anakinra Anakinra The metabolism of Erythromycin can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Desloratadine.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Erythromycin is combined with Pentosan polysulfate.
Trimipramine Trimipramine The serum concentration of Erythromycin can be increased when it is combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Erythromycin can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Erythromycin can be increased when combined with Modafinil.
Tenofovir Tenofovir The serum concentration of Tenofovir can be increased when it is combined with Erythromycin.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Erythromycin.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Erythromycin.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Erythromycin.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Escitalopram.
Olmesartan Olmesartan Erythromycin may decrease the excretion rate of Olmesartan which could result in a higher serum level.
Zonisamide Zonisamide The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Erythromycin can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Erythromycin.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Erythromycin.
Ezetimibe Ezetimibe Erythromycin may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Erythromycin which could result in a higher serum level.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Erythromycin.
Rosuvastatin Rosuvastatin The serum concentration of Rosuvastatin can be decreased when it is combined with Erythromycin.
Vardenafil Vardenafil The serum concentration of Vardenafil can be increased when it is combined with Erythromycin.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Erythromycin.
Aprepitant Aprepitant The metabolism of Aprepitant can be decreased when combined with Erythromycin.
Tegaserod Tegaserod The serum concentration of Tegaserod can be increased when it is combined with Erythromycin.
Tadalafil Tadalafil The metabolism of Tadalafil can be decreased when combined with Erythromycin.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Gemifloxacin.
Progesterone Progesterone The risk or severity of liver damage can be increased when Erythromycin is combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Erythromycin.
Infliximab Injection Infliximab Injection The metabolism of Erythromycin can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Erythromycin.
Rifaximin Rifaximin The serum concentration of Rifaximin can be increased when it is combined with Erythromycin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Erythromycin.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Erythromycin.
Tinidazole Tinidazole Erythromycin may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The risk or severity of liver damage can be increased when Erythromycin is combined with Bosentan.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Erythromycin.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Erythromycin.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Erythromycin.
Voriconazole Voriconazole The metabolism of Erythromycin can be decreased when combined with Voriconazole.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Erythromycin.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Erythromycin.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Erythromycin.
Tipranavir Tipranavir The serum concentration of Tipranavir can be increased when it is combined with Erythromycin.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Erythromycin.
Ranolazine Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Erythromycin.
Abatacept Injection Abatacept Injection The metabolism of Erythromycin can be increased when combined with Abatacept.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Imatinib.
Sitagliptin Sitagliptin The serum concentration of Sitagliptin can be increased when it is combined with Erythromycin.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Erythromycin.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Erythromycin.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Erythromycin can be decreased when combined with Bortezomib.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Oxaliplatin.
Posaconazole Posaconazole The serum concentration of Posaconazole can be increased when it is combined with Erythromycin.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Primaquine.
Darunavir Darunavir The excretion of Erythromycin can be decreased when combined with Darunavir.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Dimenhydrinate.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Erythromycin.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Erythromycin.
Sorafenib Sorafenib The metabolism of Erythromycin can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Erythromycin.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Erythromycin.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Erythromycin.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Erythromycin.
Armodafinil Armodafinil The metabolism of Erythromycin can be increased when combined with Armodafinil.
Ivermectin Ivermectin The excretion of Erythromycin can be decreased when combined with Ivermectin.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Erythromycin.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Erythromycin.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Toremifene.
Budesonide Budesonide The serum concentration of Erythromycin can be increased when it is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The therapeutic efficacy of Erythromycin can be decreased when used in combination with Chloramphenicol.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Arsenic trioxide.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Erythromycin.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Erythromycin.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Erythromycin can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Erythromycin.
Irinotecan Injection Irinotecan Injection The metabolism of Erythromycin can be decreased when combined with Irinotecan.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Erythromycin.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Erythromycin.
Silodosin Silodosin The serum concentration of Silodosin can be increased when it is combined with Erythromycin.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Erythromycin.
Eltrombopag Eltrombopag The excretion of Erythromycin can be decreased when combined with Eltrombopag.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Erythromycin.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Erythromycin.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Erythromycin.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Erythromycin is combined with Prasugrel.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Erythromycin.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Erythromycin.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The serum concentration of Tolvaptan can be increased when it is combined with Erythromycin.
Dronedarone Dronedarone The serum concentration of Dronedarone can be increased when it is combined with Erythromycin.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Erythromycin.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The serum concentration of Romidepsin can be increased when it is combined with Erythromycin.
Topotecan Topotecan The serum concentration of Topotecan can be increased when it is combined with Erythromycin.
Golimumab Injection Golimumab Injection The metabolism of Erythromycin can be increased when combined with Golimumab.
Pazopanib Pazopanib The serum concentration of Pazopanib can be increased when it is combined with Erythromycin.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Asenapine.
Pitavastatin Pitavastatin The serum concentration of Pitavastatin can be increased when it is combined with Erythromycin.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Erythromycin.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be decreased when combined with Erythromycin.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Erythromycin is combined with Dabigatran.
Tocilizumab Injection Tocilizumab Injection The metabolism of Erythromycin can be increased when combined with Tocilizumab.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Erythromycin.
Cabazitaxel Injection Cabazitaxel Injection The serum concentration of Cabazitaxel can be increased when it is combined with Erythromycin.
Lurasidone Lurasidone The metabolism of Lurasidone can be decreased when combined with Erythromycin.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Erythromycin.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Erythromycin.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Erythromycin.
Linagliptin Linagliptin The serum concentration of Linagliptin can be increased when it is combined with Erythromycin.
Rilpivirine Rilpivirine The serum concentration of Rilpivirine can be increased when it is combined with Erythromycin.
Telaprevir Telaprevir The serum concentration of Glecaprevir can be increased when it is combined with Erythromycin.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Erythromycin.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Erythromycin.
Rivaroxaban Rivaroxaban The risk or severity of bleeding can be increased when Erythromycin is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding can be increased when Erythromycin is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Erythromycin.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Erythromycin.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Erythromycin.
Clobazam Clobazam The serum concentration of Clobazam can be increased when it is combined with Erythromycin.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Erythromycin.
Ivacaftor Ivacaftor The metabolism of Erythromycin can be decreased when combined with Ivacaftor.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Erythromycin.
Crizotinib Crizotinib The serum concentration of Crizotinib can be increased when it is combined with Erythromycin.
Cabergoline Cabergoline Erythromycin may increase the vasoconstricting activities of Cabergoline.
Ambrisentan Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Erythromycin.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Erythromycin is combined with Fondaparinux.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Erythromycin.
Iloprost Iloprost The risk or severity of bleeding can be increased when Erythromycin is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Erythromycin.
Mirabegron Mirabegron The serum concentration of Mirabegron can be increased when it is combined with Erythromycin.
Regorafenib Regorafenib The serum concentration of Regorafenib can be increased when it is combined with Erythromycin.
Bosutinib Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Erythromycin.
Corticotropin, Repository Injection Corticotropin, Repository Injection The serum concentration of Corticotropin can be increased when it is combined with Erythromycin.
Teriflunomide Teriflunomide The excretion of Erythromycin can be decreased when combined with Teriflunomide.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Bedaquiline.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Erythromycin.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Erythromycin.
Pomalidomide Pomalidomide The serum concentration of Pomalidomide can be increased when it is combined with Erythromycin.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The serum concentration of Trastuzumab emtansine can be increased when it is combined with Erythromycin.
Apixaban Apixaban The risk or severity of bleeding can be increased when Erythromycin is combined with Apixaban.
Canagliflozin Canagliflozin The serum concentration of Canagliflozin can be increased when it is combined with Erythromycin.
Dabrafenib Dabrafenib The serum concentration of Dabrafenib can be increased when it is combined with Erythromycin.
Dolutegravir Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Erythromycin.
Afatinib Afatinib The serum concentration of Afatinib can be increased when it is combined with Erythromycin.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Erythromycin.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Erythromycin.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Erythromycin.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Erythromycin.
Avanafil Avanafil The metabolism of Avanafil can be decreased when combined with Erythromycin.
Simeprevir Simeprevir The risk or severity of liver damage can be increased when Erythromycin is combined with Simeprevir.
Sofosbuvir Sofosbuvir The serum concentration of Sofosbuvir can be increased when it is combined with Erythromycin.
Apremilast Apremilast The metabolism of Erythromycin can be increased when combined with Apremilast.
Ceritinib Ceritinib The serum concentration of Ceritinib can be increased when it is combined with Erythromycin.
Siltuximab Injection Siltuximab Injection The metabolism of Erythromycin can be increased when combined with Siltuximab.
Belinostat Injection Belinostat Injection The serum concentration of Belinostat can be increased when it is combined with Erythromycin.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Erythromycin.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Erythromycin.
Vorapaxar Vorapaxar The risk or severity of bleeding can be increased when Erythromycin is combined with Vorapaxar.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Erythromycin.
Edoxaban Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Erythromycin.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Erythromycin.
Caspofungin Injection Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Erythromycin.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Erythromycin.
Nintedanib Nintedanib The serum concentration of Nintedanib can be increased when it is combined with Erythromycin.
Secukinumab Injection Secukinumab Injection The metabolism of Erythromycin can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be decreased when combined with Erythromycin.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Erythromycin.
Lenvatinib Lenvatinib The risk or severity of liver damage can be increased when Erythromycin is combined with Lenvatinib.
Naloxegol Naloxegol The serum concentration of Naloxegol can be increased when it is combined with Erythromycin.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Erythromycin.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Erythromycin which could result in a lower serum level and potentially a reduction in efficacy.
Ivabradine Ivabradine The metabolism of Ivabradine can be decreased when combined with Erythromycin.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Erythromycin.
Flibanserin Flibanserin The metabolism of Erythromycin can be decreased when combined with Flibanserin.
Prednisolone Prednisolone The serum concentration of Prednisolone can be increased when it is combined with Erythromycin.
Daclatasvir Daclatasvir The metabolism of Erythromycin can be decreased when combined with Daclatasvir.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Erythromycin.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ziprasidone.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Erythromycin.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Erythromycin.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Erythromycin.
Osimertinib Osimertinib The serum concentration of Osimertinib can be increased when it is combined with Erythromycin.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Erythromycin.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Erythromycin.
Dexamethasone Injection Dexamethasone Injection The serum concentration of Dexamethasone can be increased when it is combined with Erythromycin.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Erythromycin is combined with Defibrotide.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Erythromycin.
Cobicistat Cobicistat The metabolism of Erythromycin can be decreased when combined with Cobicistat.
Selexipag Selexipag The serum concentration of Selexipag can be increased when it is combined with Erythromycin.
Obeticholic Acid Obeticholic Acid The risk or severity of adverse effects can be increased when Erythromycin is combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Erythromycin.
Rucaparib Rucaparib The serum concentration of Rucaparib can be increased when it is combined with Erythromycin.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Erythromycin.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of QTc prolongation can be increased when Doxepin is combined with Erythromycin.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Erythromycin.
Deflazacort Deflazacort The serum concentration of Erythromycin can be increased when it is combined with Deflazacort.
Safinamide Safinamide The metabolism of Erythromycin can be decreased when combined with Safinamide.
Midostaurin Midostaurin The metabolism of Erythromycin can be decreased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Erythromycin.
Enasidenib Enasidenib The metabolism of Erythromycin can be decreased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Erythromycin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Erythromycin.
Copanlisib Injection Copanlisib Injection The serum concentration of Copanlisib can be increased when it is combined with Erythromycin.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Erythromycin.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Erythromycin.
Betrixaban Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Erythromycin.
Acalabrutinib Acalabrutinib The metabolism of Erythromycin can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The risk or severity of liver damage can be increased when Erythromycin is combined with Letermovir.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The serum concentration of Ertugliflozin can be increased when it is combined with Erythromycin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Erythromycin.
Apalutamide Apalutamide The excretion of Erythromycin can be increased when combined with Apalutamide.
Penicillamine Penicillamine The excretion of Penicillamine can be decreased when combined with Erythromycin.
Avatrombopag Avatrombopag The serum concentration of Avatrombopag can be increased when it is combined with Erythromycin.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Erythromycin.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Lofexidine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Erythromycin.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Encorafenib.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Erythromycin.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Erythromycin.
Lusutrombopag Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Erythromycin.
Elagolix Elagolix The serum concentration of Elagolix can be increased when it is combined with Erythromycin.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Erythromycin.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Erythromycin.
Dacomitinib Dacomitinib The serum concentration of Dacomitinib can be increased when it is combined with Erythromycin.
Duvelisib Duvelisib The serum concentration of Duvelisib can be increased when it is combined with Erythromycin.
Omadacycline Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Erythromycin.
Talazoparib Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Erythromycin.
Gilteritinib Gilteritinib The serum concentration of Gilteritinib can be increased when it is combined with Erythromycin.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Erythromycin.
Larotrectinib Larotrectinib The serum concentration of Larotrectinib can be increased when it is combined with Erythromycin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Erythromycin.
Rifamycin Rifamycin The serum concentration of Rifamycin can be increased when it is combined with Erythromycin.
Prucalopride Prucalopride The serum concentration of Erythromycin can be increased when it is combined with Prucalopride.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Erythromycin can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Erythromycin is combined with Siponimod.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Erythromycin.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Erythromycin.
Selinexor Selinexor The excretion of Erythromycin can be decreased when combined with Selinexor.
Darolutamide Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Erythromycin.
Triclabendazole Triclabendazole The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Erythromycin.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Erythromycin.
Pexidartinib Pexidartinib The metabolism of Erythromycin can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Erythromycin.
Pitolisant Pitolisant The serum concentration of Erythromycin can be decreased when it is combined with Pitolisant.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Erythromycin.
Fedratinib Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Erythromycin.
Lefamulin Lefamulin Erythromycin may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be decreased when combined with Erythromycin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Erythromycin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Erythromycin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Erythromycin.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Erythromycin.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Erythromycin.
Lasmiditan Lasmiditan The serum concentration of Lasmiditan can be increased when it is combined with Erythromycin.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Erythromycin.
Tazemetostat Tazemetostat The serum concentration of Tazemetostat can be increased when it is combined with Erythromycin.
Bempedoic Acid Bempedoic Acid The excretion of Erythromycin can be decreased when combined with Bempedoic acid.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Erythromycin.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Erythromycin.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Erythromycin.
Rimegepant Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Erythromycin.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Erythromycin.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Erythromycin.
Ripretinib Ripretinib The serum concentration of Ripretinib can be increased when it is combined with Erythromycin.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Erythromycin.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Erythromycin.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Erythromycin.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Erythromycin.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Erythromycin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib The serum concentration of Erythromycin can be increased when it is combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Erythromycin can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The serum concentration of Relugolix can be increased when it is combined with Erythromycin.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Erythromycin can be decreased when combined with Drospirenone.
Theophylline Theophylline The therapeutic efficacy of Erythromycin can be decreased when used in combination with Theophylline.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Erythromycin which could result in a higher serum level.
Naproxen Naproxen Erythromycin may decrease the excretion rate of Naproxen which could result in a higher serum level.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Erythromycin.
Phenobarbital Phenobarbital The metabolism of Erythromycin can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Erythromycin.
Methsuximide Methsuximide The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Methsuximide.
Chlorpromazine Chlorpromazine The risk or severity of liver damage can be increased when Erythromycin is combined with Chlorpromazine.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Erythromycin.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Erythromycin.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Erythromycin.
Bromocriptine Bromocriptine Erythromycin may increase the vasoconstricting activities of Bromocriptine.
Phenelzine Phenelzine The metabolism of Erythromycin can be decreased when combined with Phenelzine.
Ergoloid Mesylates Ergoloid Mesylates Erythromycin may increase the vasoconstricting activities of Ergoloid mesylate.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Prochlorperazine.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Thioridazine.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Erythromycin.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Erythromycin.
Methadone Methadone The metabolism of Methadone can be decreased when combined with Erythromycin.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Erythromycin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Erythromycin.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Erythromycin.
Orphenadrine Orphenadrine The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Erythromycin.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Erythromycin.
Amoxapine Amoxapine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Erythromycin.
Sulfasalazine Sulfasalazine The excretion of Erythromycin can be decreased when combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The serum concentration of Hydrocortisone can be increased when it is combined with Erythromycin.
Doxorubicin Doxorubicin The serum concentration of Doxorubicin can be increased when it is combined with Erythromycin.
Dactinomycin Dactinomycin The serum concentration of Dactinomycin can be increased when it is combined with Erythromycin.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Erythromycin.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Erythromycin.
Cimetidine Cimetidine The risk or severity of liver damage can be increased when Erythromycin is combined with Cimetidine.
Warfarin Warfarin The risk or severity of bleeding can be increased when Erythromycin is combined with Warfarin.
Loperamide Loperamide The serum concentration of Loperamide can be increased when it is combined with Erythromycin.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Promethazine is combined with Erythromycin.
Daunorubicin Daunorubicin Erythromycin may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Erythromycin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin The serum concentration of Digoxin can be increased when it is combined with Erythromycin.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Erythromycin.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Ethosuximide.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Erythromycin.
Sulfinpyrazone Sulfinpyrazone Erythromycin may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Clindamycin Injection Clindamycin Injection The therapeutic efficacy of Erythromycin can be decreased when used in combination with Clindamycin.
Desipramine Desipramine The risk or severity of QTc prolongation can be increased when Desipramine is combined with Erythromycin.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Erythromycin.
Imipramine Imipramine The serum concentration of Imipramine can be increased when it is combined with Erythromycin.
Quinidine Quinidine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Quinidine.
Procainamide Procainamide The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Procainamide.
Rifampin Rifampin The metabolism of Erythromycin can be increased when combined with Rifampicin.
Disopyramide Disopyramide Erythromycin may increase the QTc-prolonging activities of Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Erythromycin.
Levothyroxine Levothyroxine The excretion of Erythromycin can be decreased when combined with Levothyroxine.
Liothyronine Liothyronine The excretion of Liothyronine can be decreased when combined with Erythromycin.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Erythromycin.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Erythromycin.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Erythromycin.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Erythromycin.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Erythromycin.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Erythromycin.
Disulfiram Disulfiram Erythromycin may decrease the excretion rate of Disulfiram which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Erythromycin.
Nortriptyline Nortriptyline The serum concentration of Erythromycin can be increased when it is combined with Nortriptyline.
Spironolactone Spironolactone Erythromycin may decrease the excretion rate of Spironolactone which could result in a higher serum level.
Mercaptopurine Mercaptopurine The metabolism of Mercaptopurine can be decreased when combined with Erythromycin.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Erythromycin.
Clomiphene Clomiphene The serum concentration of Clomifene can be increased when it is combined with Erythromycin.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Fluorouracil.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Erythromycin.
Cefaclor Cefaclor Erythromycin may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Erythromycin.
Nystatin Nystatin The excretion of Erythromycin can be decreased when combined with Nystatin.
Ketoconazole Ketoconazole The metabolism of Ketoconazole can be decreased when combined with Erythromycin.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Erythromycin.
Vincristine Injection Vincristine Injection The excretion of Vincristine can be decreased when combined with Erythromycin.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Erythromycin is combined with Dipyridamole.
Vinblastine Vinblastine The metabolism of Vinblastine can be decreased when combined with Erythromycin.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Erythromycin.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Erythromycin.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Erythromycin.
Aspirin Aspirin The risk or severity of bleeding can be increased when Erythromycin is combined with Acetylsalicylic acid.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Erythromycin.
Triazolam Triazolam The serum concentration of Triazolam can be increased when it is combined with Erythromycin.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Erythromycin.
Diltiazem Diltiazem The risk or severity of adverse effects can be increased when Erythromycin is combined with Diltiazem.
Nifedipine Nifedipine The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nifedipine.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Erythromycin.
Verapamil Verapamil The risk or severity of adverse effects can be increased when Erythromycin is combined with Verapamil.
Atenolol Atenolol Erythromycin may decrease the excretion rate of Atenolol which could result in a higher serum level.
Etoposide Etoposide The serum concentration of Etoposide can be increased when it is combined with Erythromycin.
Glyburide Glyburide The risk or severity of liver damage can be increased when Erythromycin is combined with Glyburide.
Glipizide Glipizide Erythromycin may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Erythromycin.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Erythromycin.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Pentamidine.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Erythromycin.
Gemfibrozil Gemfibrozil The excretion of Erythromycin can be decreased when combined with Gemfibrozil.
Pimozide Pimozide The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Erythromycin is combined with Pimozide.
Enalapril Enalapril The excretion of Enalapril can be decreased when combined with Erythromycin.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Erythromycin.
Buspirone Buspirone The serum concentration of Buspirone can be increased when it is combined with Erythromycin.
Lovastatin Lovastatin The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.
Ciprofloxacin Ciprofloxacin The metabolism of Erythromycin can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Erythromycin which could result in a higher serum level.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nimodipine.
Clozapine Clozapine The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Clozapine.
Estazolam Estazolam The serum concentration of Estazolam can be increased when it is combined with Erythromycin.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Ofloxacin.
Clarithromycin Clarithromycin The metabolism of Erythromycin can be decreased when combined with Clarithromycin.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Erythromycin.
Pravastatin Pravastatin The risk or severity of myopathy and rhabdomyolysis can be increased when Erythromycin is combined with Pravastatin.
Simvastatin Simvastatin The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.
Amlodipine Amlodipine The risk or severity of adverse effects can be increased when Erythromycin is combined with Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Erythromycin.
Itraconazole Itraconazole The metabolism of Erythromycin can be decreased when combined with Itraconazole.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Sotalol.
Bisoprolol Bisoprolol The serum concentration of Bisoprolol can be increased when it is combined with Erythromycin.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Erythromycin.
Isradipine Isradipine The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Isradipine.
Cisapride Cisapride The serum concentration of Cisapride can be increased when it is combined with Erythromycin.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Erythromycin.
Venlafaxine Venlafaxine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Erythromycin.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Erythromycin.
Fluvoxamine Fluvoxamine Erythromycin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Nefazodone Nefazodone Nefazodone may decrease the excretion rate of Erythromycin which could result in a higher serum level.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Lamotrigine.
Losartan Losartan Erythromycin may decrease the excretion rate of Losartan which could result in a higher serum level.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Erythromycin.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Erythromycin.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Erythromycin.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Erythromycin.
Nicardipine Nicardipine The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Nicardipine.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Erythromycin.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Erythromycin.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Erythromycin is combined with Dalteparin.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be decreased when combined with Erythromycin.
Glimepiride Glimepiride Erythromycin may decrease the excretion rate of Glimepiride which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection The serum concentration of Gemcitabine can be increased when it is combined with Erythromycin.
Indinavir Indinavir The metabolism of Indinavir can be decreased when combined with Erythromycin.
Ritonavir Ritonavir The serum concentration of Erythromycin can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Erythromycin.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Erythromycin.
Zafirlukast Zafirlukast The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Erythromycin.
Valsartan Valsartan The excretion of Erythromycin can be decreased when combined with Valsartan.
Nelfinavir Nelfinavir The metabolism of Erythromycin can be decreased when combined with Nelfinavir.
Fexofenadine Fexofenadine Erythromycin can cause an increase in the absorption of Fexofenadine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Erythromycin.
Loratadine Loratadine Erythromycin may decrease the excretion rate of Loratadine which could result in a higher serum level.
Carvedilol Carvedilol The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Carvedilol.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Erythromycin.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Erythromycin.
Propafenone Propafenone The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Propafenone.
Raloxifene Raloxifene The excretion of Raloxifene can be decreased when combined with Erythromycin.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Erythromycin.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Erythromycin.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Erythromycin.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Citalopram.
Efavirenz Efavirenz The metabolism of Erythromycin can be increased when combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Erythromycin.
Celecoxib Celecoxib The risk or severity of liver damage can be increased when Celecoxib is combined with Erythromycin.
Rosiglitazone Rosiglitazone Erythromycin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Erythromycin.
Thalidomide Thalidomide The metabolism of Erythromycin can be increased when combined with Thalidomide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Erythromycin.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Erythromycin.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists